2022 Annual Meeting | C126 - Cefalea: viejos y nuevos conceptos y estrategias (Headache)
Program Materials Program Evaluations
07:00 AM - 07:05 AM PDT | Introduction |
Introducción
Gloria P. Simms, MD, FAAN |
07:00 AM - 07:00 AM PDT | Speaker |
Walk-in Slides
Gloria P. Simms, MD, FAAN |
07:05 AM - 07:35 AM PDT | Speaker |
Cefaleas primarias y secundarias: aspectos generales
Gloria P. Simms, MD, FAAN |
07:35 AM - 07:40 AM PDT | Break |
Transición
|
07:40 AM - 08:10 AM PDT | Speaker |
Tratamiento agudo para migraña: viejas y nuevas estrategias
Gloria P. Simms, MD, FAAN |
08:10 AM - 08:15 AM PDT | Break |
Transición
|
08:15 AM - 08:45 AM PDT | Speaker |
Prevención en migraña: explorando el nuevo panorama de tratamiento
Cristina M. Cabret-Aymat, MD |
08:45 AM - 09:00 AM PDT | Q&A |
Preguntas y respuestas
Gloria P. Simms, MD, FAAN, Cristina M. Cabret-Aymat, MD |
Gloria P. Simms, MD, FAAN | Dr. Simms has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Simms has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie . |
Cristina M. Cabret-Aymat, MD | Dr. Cabret-Aymat has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. |